Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Pilot study shows Symlin improves daily glucose profile in type 1 diabetes patients

Jan. 11, 2002

CT-025 as an effective means of delivering calcitonin by oral administration

Jan. 11, 2002

FDA approves Pravachol 80 mg

Jan. 11, 2002

New Kissei compounds have potential for lowering lipids and protecting the liver

Jan. 10, 2002

Potent and selective OX2 receptor antagonists identified by Banyu

Jan. 10, 2002

Avaden hormone replacement therapy receives French approval

Jan. 10, 2002

Successful completion of clinical trial of inhaled human growth hormone

Jan. 10, 2002

AstraZeneca patents novel neuropeptide Y5 receptor antagonists

Jan. 9, 2002

New growth hormone secretagogues and their use described by BMS

Jan. 9, 2002

Marketing approval obtained for Replagal in Israel, Switzerland and Czech Republic

Jan. 9, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 23, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
Nankai University and Accendatech present new majusculamide D derivatives
BioWorld Science
Scientists from Nankai University Tianjin and Accendatech Technology Co. Ltd. have identified a majusculamide D derivative found to be useful for the treatment of...